BOZEMAN, MT and VANCOUVER, BC, April 15, 2024 /CNW/ - Microbion Corporation today announced that the company has been selected to present topical pravibismane for the treatment of diabetic foot infection (DFI) at the Advanced Wound Care Summit USA held at the Boston Marriot Long Wharf from April 16th to 17th. Karim Lalji, Microbion's CEO, will be presenting during the Innovation Showcase portion of the summit on April 17 at 9:30am in the Grand Ballroom. The presentation will focus on topical pravibismane's clinical safety and efficacy for the treatment of moderate to severe DFI and future development plans.
Read more at newswire.caProvided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.